Warning: Last items in stock!
Hepcvir L, also known as “HARVONI®, Hepcinat-LP, Myhep lvir” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Hepcvilr L combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C. Sofosbuvir 100mg/Velpatasvir 40 mg’s brand name is HARVONI® by Gilead. Hepcvilr L is a generic oncologic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.
|Warnings||Don't take the drug without consulting a qualified doctor or physician|
|Suggested use||Follow the doctor's advice|
|Delivery & Returns||7-14 Days|